PTSD Trial, Recruiting NCT06093906 Sponsor: Case Western Reserve University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06093906
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who experienced a major life event involving serious loss or threat, where the event happened at least 12 weeks ago but within the last 5 years.
  • People who are between 18 and 65 years of age.
  • People who score at a moderate level or higher on at least 2 of 3 specific areas measured by screening questionnaires: repeatedly reliving or dwelling on the event, avoiding reminders of the event, or having reduced ability to feel pleasure or reward (confirm with trial site for exact scoring details).

Who may not be able to join:

  • People who currently have a diagnosis of schizophrenia, delusional disorder, or a mental disorder caused by a physical/medical condition.
  • People who currently have a diagnosis of bipolar disorder, depression with psychotic features, or depression that is severe enough to need urgent psychiatric care, including serious risk of suicide with a specific intent and plan.
  • People who have engaged in severe self-harm or made a suicide attempt within the past three months.
  • People who are unwilling or unable to stop a current course of cognitive behavioural therapy (a specific type of talk therapy).
  • People who do not have a clear memory of the destabilizing event, or whose event occurred before they were 3 years old.
  • People whose dose of psychiatric medications has not been stable for at least the past 3 months.
  • People who are currently in a relationship with the person who carried out an assault (where the event involved an assault).
  • People who currently have a diagnosis of a substance use disorder.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Norah Feeny, PhD, Case Western Reserve University

Phone: 216-368-0338

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Case Western Reserve University
Registry
ClinicalTrials.gov
Start date
12 September 2023
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Affective Updating Task; Idiographic Behavioral Approach Task; Probabilistic Reward Task

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov